The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
TB Diagnostic-Global Market Insights and Sales Trends 2024
Synopsis
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global TB Diagnostic market size is expected to reach US$ 3316.9 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of TB Diagnostic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling TB Diagnostic market. Radiographic Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Laboratory Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TB Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TB Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TB Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TB Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TB Diagnostic covered in this report include Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation and Thermo Fisher Scientific, etc.
The global TB Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Abbott
Becton Dickinson and Company
bioMrieux
Cepheid
F. Hoffman La Roche
Hain Lifescience
Hologic Corporation
Thermo Fisher Scientific
Qiagen
Global TB Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Diagnostic market, Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
Global TB Diagnostic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TB Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global TB Diagnostic market size is expected to reach US$ 3316.9 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of TB Diagnostic in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling TB Diagnostic market. Radiographic Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Laboratory Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TB Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TB Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TB Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TB Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TB Diagnostic covered in this report include Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation and Thermo Fisher Scientific, etc.
The global TB Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Abbott
Becton Dickinson and Company
bioMrieux
Cepheid
F. Hoffman La Roche
Hain Lifescience
Hologic Corporation
Thermo Fisher Scientific
Qiagen
Global TB Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Diagnostic market, Segment by Type:
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
Global TB Diagnostic market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TB Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of TB Diagnostic
1.1 TB Diagnostic Market Overview
1.1.1 TB Diagnostic Product Scope
1.1.2 TB Diagnostic Market Status and Outlook
1.2 Global TB Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global TB Diagnostic Market Size by Region (2018-2029)
1.4 Global TB Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global TB Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, TB Diagnostic Market Size (2018-2029)
1.6.1 North America TB Diagnostic Market Size (2018-2029)
1.6.2 Europe TB Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific TB Diagnostic Market Size (2018-2029)
1.6.4 Latin America TB Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa TB Diagnostic Market Size (2018-2029)
2 TB Diagnostic Market by Type
2.1 Introduction
2.1.1 Radiographic Method
2.1.2 Diagnostic Laboratory Methods
2.1.3 Nucleic Acid Testing
2.1.4 Phage Assay
2.1.5 Detection of Latent Infection
2.1.6 Cytokine Detection Assay
2.1.7 Detection of Drug Resistance
2.1.8 Others
2.2 Global TB Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global TB Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global TB Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America TB Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe TB Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific TB Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America TB Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa TB Diagnostic Revenue Breakdown by Type (2018-2029)
3 TB Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global TB Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global TB Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global TB Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America TB Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe TB Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific TB Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America TB Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa TB Diagnostic Revenue Breakdown by Application (2018-2029)
4 TB Diagnostic Competition Analysis by Players
4.1 Global TB Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TB Diagnostic as of 2022)
4.3 Date of Key Players Enter into TB Diagnostic Market
4.4 Global Top Players TB Diagnostic Headquarters and Area Served
4.5 Key Players TB Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 TB Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories TB Diagnostic Products, Services and Solutions
5.1.4 Abbott Laboratories TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott TB Diagnostic Products, Services and Solutions
5.2.4 Abbott TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Becton Dickinson and Company
5.3.1 Becton Dickinson and Company Profile
5.3.2 Becton Dickinson and Company Main Business
5.3.3 Becton Dickinson and Company TB Diagnostic Products, Services and Solutions
5.3.4 Becton Dickinson and Company TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 bioMrieux Recent Developments
5.4 bioMrieux
5.4.1 bioMrieux Profile
5.4.2 bioMrieux Main Business
5.4.3 bioMrieux TB Diagnostic Products, Services and Solutions
5.4.4 bioMrieux TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 bioMrieux Recent Developments
5.5 Cepheid
5.5.1 Cepheid Profile
5.5.2 Cepheid Main Business
5.5.3 Cepheid TB Diagnostic Products, Services and Solutions
5.5.4 Cepheid TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Cepheid Recent Developments
5.6 F. Hoffman La Roche
5.6.1 F. Hoffman La Roche Profile
5.6.2 F. Hoffman La Roche Main Business
5.6.3 F. Hoffman La Roche TB Diagnostic Products, Services and Solutions
5.6.4 F. Hoffman La Roche TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 F. Hoffman La Roche Recent Developments
5.7 Hain Lifescience
5.7.1 Hain Lifescience Profile
5.7.2 Hain Lifescience Main Business
5.7.3 Hain Lifescience TB Diagnostic Products, Services and Solutions
5.7.4 Hain Lifescience TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Hain Lifescience Recent Developments
5.8 Hologic Corporation
5.8.1 Hologic Corporation Profile
5.8.2 Hologic Corporation Main Business
5.8.3 Hologic Corporation TB Diagnostic Products, Services and Solutions
5.8.4 Hologic Corporation TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Hologic Corporation Recent Developments
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Profile
5.9.2 Thermo Fisher Scientific Main Business
5.9.3 Thermo Fisher Scientific TB Diagnostic Products, Services and Solutions
5.9.4 Thermo Fisher Scientific TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Thermo Fisher Scientific Recent Developments
5.10 Qiagen
5.10.1 Qiagen Profile
5.10.2 Qiagen Main Business
5.10.3 Qiagen TB Diagnostic Products, Services and Solutions
5.10.4 Qiagen TB Diagnostic Revenue (US$ Million) & (2018-2023)
5.10.5 Qiagen Recent Developments
6 North America
6.1 North America TB Diagnostic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe TB Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific TB Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America TB Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa TB Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 TB Diagnostic Market Dynamics
11.1 TB Diagnostic Industry Trends
11.2 TB Diagnostic Market Drivers
11.3 TB Diagnostic Market Challenges
11.4 TB Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
